title: ESAs and irons in the pipeline: how do they differ?
authors.affiliation: Henry Ford Hospital, Detroit, USA.
authors.forename: Anatole
authors.initials: A
authors.lastname: Beserab
mesh_terms: D000740:Anemia / Q000097:blood / Q000178:diet therapy* / Q000209:etiology; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000627:therapeutic use*; D006397:Hematinics / Q000627:therapeutic use; D006801:Humans; D007501:Iron / Q000097:blood / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D051436:Renal Insufficiency, Chronic / Q000150:complications*
chemical_list: D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa; D007501:Iron